Free Trial
OTCMKTS:KYKOF

Kyowa Kirin (KYKOF) Stock Price, News & Analysis

$16.40
0.00 (0.00%)
(As of 05/21/2024 ET)
Today's Range
$16.40
$16.40
50-Day Range
$16.40
$19.89
52-Week Range
$15.78
$20.31
Volume
129 shs
Average Volume
2,192 shs
Market Capitalization
N/A
P/E Ratio
0.48
Dividend Yield
121.60%
Price Target
N/A
KYKOF stock logo

About Kyowa Kirin Stock (OTCMKTS:KYKOF)

Kyowa Kirin Co., Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor. The company also develops GRAN /Peglasta/Neulasta for chemotherapy-induced febrile neutropenia; LUMICEF, a biological treatment for moderate to severe plaque psoriasis; Moventig, a mu-opioid receptor antagonist for the treatment of opioid induced constipation; Nouriast/ Nourianz, an adenosine receptor antagonist for Parkinson's disease; and ORKEDIA, an oral calcimimetics agent. In addition, it offers POTELIGEO, a humanized monoclonal antibody for CC chemokine receptor 4; REGPARA for the treatment of secondary hyperparathyroidism; and Romiplate/Nplate, a genetically recombinant protein that produces platelet through the stimulation of thrombopoietin receptors. Kyowa Kirin Co., Ltd. has an agreement with Amgen Inc. to jointly develop and commercialize KHK4083, an anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis. The company was formerly known as Kyowa Hakko Kirin Co., Ltd. and changed its name to Kyowa Kirin Co., Ltd. in June 2019. The company was incorporated in 1949 and is headquartered in Tokyo, Japan. Kyowa Kirin Co., Ltd. is a subsidiary of Kirin Holdings Company, Limited.

KYKOF Stock Price History

KYKOF Stock News Headlines

Kyowa Kirin (OTCMKTS:KYKOF) Stock Price Up 2.4%
KYKOY Kyowa Kirin Co., Ltd.
Kyowa Kirin Co Ltd (KY4.SG)
KYKOF Kyowa Kirin Co., Ltd.
See More Headlines
Receive KYKOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kyowa Kirin and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
Current Symbol
OTCMKTS:KYKOF
CIK
N/A
Fax
N/A
Employees
5,974
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Masashi Miyamoto Ph.D. (Age 65)
    President, CEO & Representative Director
    Comp: $824.32k
  • Mr. Motohiko Kawaguchi
    CFO, Managing Executive Officer & Head of Global Finance
  • Mr. Yutaka Osawa M.B.A. (Age 65)
    CCO, Executive VP & Representative Director
    Comp: $502.32k
  • Kazuki Nemoto
    Head of Global Legal
  • Satoko Yoshida M.B.A.
    Head of Global Corporate Communications
  • Hiroshi Sonekawa
    Managing Executive Officer, VP and Head of Sales & Marketing Division
  • Wataru Murata M.B.A.
    Chief People Officer & Head of Global Human Resources
  • Mr. Takeyoshi Yamashita Ph.D. (Age 63)
    Chief Medical Officer, Senior Managing Executive Officer & Director
  • Yasuo Fujii M.B.A.
    Chief Strategy Officer, VP & Managing Executive Officer
  • Jean-David Rafizadeh-Kabe J.D.
    M.D., Head of Global Operational Transformation

KYKOF Stock Analysis - Frequently Asked Questions

How have KYKOF shares performed in 2024?

Kyowa Kirin's stock was trading at $16.75 on January 1st, 2024. Since then, KYKOF stock has decreased by 2.1% and is now trading at $16.3970.
View the best growth stocks for 2024 here
.

Is Kyowa Kirin a good dividend stock?

Kyowa Kirin (OTCMKTS:KYKOF) pays an annual dividend of $19.94 per share and currently has a dividend yield of 1.56%. The dividend payout ratio is 58.08%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Kyowa Kirin?

Shares of KYKOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:KYKOF) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners